Impact of COVID-19 on Prevention of Urinary Stones with Hydration (PUSH) Study: Challenges and Opportunities for Future Trials
The Urinary Stone Disease Research Network (USDRN) Investigators
Abstract
No AccessJournal of UrologyJU Forum1 Sep 2021Impact of COVID-19 on Prevention of Urinary Stones with Hydration (PUSH) Study: Challenges and Opportunities for Future Trials The Urinary Stone Disease Research Network (USDRN) Investigators The Urinary Stone Disease Research Network (USDRN) Investigators View All Author Informationhttps://doi.org/10.1097/JU.0000000000001833AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1. : Clinical trials in urology: predictors of successes and failures. J Urol 2020; 204: 805. Link, Google Scholar 2. : Prevention of Urinary Stones with Hydration (PUSH): design and rationale of a clinical trial. Am J Kidney Dis 2021; 77: 898. Google Scholar 3. : An observational study of the association of video- versus text-based informed consent with multicenter trial enrollment: lessons from the PALM study (Patient and Provider Assessment of Lipid Management). Circ Cardiovasc Qual Outcomes 2018; 11: e004675. Google Scholar This research was supported by the National Institutes of Health/NIDDK, as follows: U01DK110961 (UPenn/CHOP—PP Reese, GE Tasian), U01KD110986 (Washington University in St. Louis—AC Desai, HH Lai), U01DK110994 (UT Southwestern—NM Maalouf), U01DK110954 (University of Washington—JD Harper, H Wessells), and U01DK110988 (Duke University—CD Scales, HR Al-Khalidi). Financial interest and/or other relationship with Allena Pharmaceuticals (CD Scales). © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue 3September 2021Page: 502-504 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.AcknowledgmentsUrinary Stone Disease Research Network: The following individuals were instrumental in the planning and conduct of the PUSH study at each of the participating institutions. Clinical Centers: University of Pennsylvania/Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania: Principal Investigator: Peter P. Reese, MD, MSCE, Gregory E. Tasian, MD, MSCE; Co-Investigators: Sandra Amaral, MD, MHS, Janet Audrain-McGovern, PhD; Study Coordinators: Emily Funsten, Brittney Henderson, Kristen Koepsell, Adam Mussell. University of Texas Southwestern Medical Center, Dallas, Texas: Principal Investigator: Naim M. Maalouf, MD; Co-Investigators: Jodi A. Antonelli, MD, Linda A. Baker, MD, Margaret S. Pearle, MD, PhD, Lakshmi Ananthakrishnan, MD; Study Coordinators: Joyce Obiaro, Cynthia Rangel, Martinez Hill, Madeline Worsham. University of Washington, Seattle, Washington: Principal Investigator: Jonathan D. Harper, MD, Hunter Wessells, MD; Co-Investigators: Fionnuala Cormack, MD, Mathew Sorensen, MD, Karyn Yonekawa, MD; Study Coordinators: Holly Covert, Tristan Baxter, Elsa Ayala. Washington University in St. Louis, St. Louis, Missouri: Principal Investigator: Alana C. Desai, MD, H. Henry Lai, MD; Co-Investigators: Vincent Mellnick, MD, Douglas Coplen, MD; Study Coordinators: Juanita Taylor, Aleksandra Klim, Deborah Ksiazek. Recruiting Centers: Cleveland Clinic Foundation, Cleveland, Ohio: Principal Investigator: Sri Sivalingam, MD, MSc, FRCSC; Co-Investigators: Katherine Dell, MD, Juan Calle, MD; Study Coordinators: Paige Gotwald, Marina Markovic. Mayo Clinic Foundation, Rochester, Minnesota: Principal Investigator: John Lieske, MD; Co-Investigators: Andrew Rule, MD, Stephen Erickson, MD, Aaron Potrezke, MD, Andrea Ferrero, PhD, David Sas, DO; Study Coordinators: Angela Waits, Courtney Lenort. Scientific Data Research Center: Duke Clinical Research Institute, Duke University, Durham, North Carolina: Principal Investigator: Charles D. Scales, Jr., MD, MSHS, Hussein R. Al-Khalidi, PhD; Co-Investigators: Kevin Weinfurt, PhD, Hayden Bosworth, MD; Statistician: Honqiu Yang, PhD; Project Lead: Laura Johnson; Lead CRA: Sharon Settles; CRA: Angela Venetta; Data Manager: Omar Thompson. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Project Scientist: Ziya Kirkali, MD; Program Official: Christopher Mullins, PhD. Data Safety and Monitoring Board: John Denstedt, MD (Chair), Dean G. Assimos, MD, Uri Alon, MD, Scott Cohen, MD, Michael A Freeman, MD, Rebecca A Krukowski, PhD, Jeannette Lee, PhD, Eric Taylor, MD, Jennifer Temple, PhD, Christopher H Schmid, PhD. Past members: Gary C. Curhan, MD, ScD, David S. Goldfarb, MD, Manoj Monga, MD, FACS, Andrew Rule, MD, Marshall Stoller, MD.Metrics Author Information The Urinary Stone Disease Research Network (USDRN) Investigators More articles by this author Expand All This research was supported by the National Institutes of Health/NIDDK, as follows: U01DK110961 (UPenn/CHOP—PP Reese, GE Tasian), U01KD110986 (Washington University in St. Louis—AC Desai, HH Lai), U01DK110994 (UT Southwestern—NM Maalouf), U01DK110954 (University of Washington—JD Harper, H Wessells), and U01DK110988 (Duke University—CD Scales, HR Al-Khalidi). Financial interest and/or other relationship with Allena Pharmaceuticals (CD Scales). Advertisement PDF downloadLoading ...